Your insulin price can change even if your insurance plan doesn’t. Formulary updates, PBM negotiations, and manufacturer agreements often affect what you pay at the pharmacy. Pixel-Shot/Shutterstock
Before he died, my father had a rough battle with diabetes. Managing the disease is challenging enough without being surprised by a higher pharmacy bill, or worse yet, a medication you can’t even afford. Yet many people discover that the amount they pay for insulin changes even though they haven’t switched employers, changed insurance companies, or selected a new health plan. That can leave patients wondering whether a mistake was made or if their insurance suddenly stopped covering their medication.
Insulin prices can change because of behind-the-scenes updates involving pharmacy benefit managers (PBMs), formularies, manufacturer discounts, and annual contract negotiations, not necessarily because your insurance changed. Here is why the price of your insulin may have changed (even if nothing else did).
Your Insurance Plan May Stay the Same, but Your Drug Formulary Can Change
Many people assume their prescription coverage stays exactly the same throughout the year if they keep the same insurance plan. However, insurers and pharmacy benefit managers periodically update their formularies. Diabetes advocacy organizations have spoken out about the fact that formulary changes often occur after annual contracting cycles and can significantly affect what patients pay at the pharmacy.
A formulary is simply your insurance plan’s approved list of covered prescription drugs. Medications are often placed into different pricing tiers, and those tiers can change during annual contract updates. If your insulin moves to a less-preferred tier (or another brand becomes the preferred option), your out-of-pocket cost may change even though your insurance plan stays exactly the same. These decisions are typically based on negotiations between PBMs and drug manufacturers rather than differences in how well the medications work for most patients.
Behind-the-Scenes Negotiations Can Affect Your Out-of-Pocket Cost
One of the least understood parts of prescription drug pricing is the role of pharmacy benefit managers (PBMs). PBMs act as intermediaries between insurers, employers, pharmacies, and drug manufacturers. They negotiate rebates, determine which drugs receive preferred formulary placement, and influence what many patients ultimately pay at the pharmacy counter. Their contracting decisions can affect insulin costs even when an insurance plan itself doesn’t change.
Even when your health insurance policy stays exactly the same, a different rebate agreement could change which insulin receives preferred coverage or how much you pay at the pharmacy. Recent Federal Trade Commission actions against major PBMs have focused on allegations that rebate practices contributed to higher insulin list prices, resulting in settlements intended to increase transparency and pass more savings to consumers.
Your Copay Isn’t Always Based on the Drug’s True Cost
Many patients understandably assume their copay reflects the actual price of their insulin, but that’s often not how prescription benefits work. Depending on your plan design, your out-of-pocket cost may be tied to a drug’s formulary tier, deductible status, coinsurance percentage, or negotiated reimbursement rather than the manufacturer’s list price.
Two people with the same insulin prescription may pay dramatically different amounts simply because their employers selected different pharmacy benefit structures. That’s one reason insulin costs can seem unpredictable even among people with similar insurance coverage. Researchers continue to point to the complexity of the drug pricing systemincluding manufacturers, PBMs, insurers, pharmacies, and rebates, as a major contributor to patient confusion about insulin pricing.
Medicare and Private Insurance Follow Different Rules
If you’re covered by Medicare, your insulin costs may look very different from someone with employer-sponsored insurance. Thanks to provisions in the Inflation Reduction Act, Medicare beneficiaries generally pay no more than $35 for a one-month supply of covered insulin, regardless of whether they’ve met their deductible. Private insurance plans, however, don’t all follow the same cost-sharing rules, although some states and employers have adopted their own insulin caps. That means two neighbors taking the exact same insulin could have very different pharmacy bills depending on the type of insurance they carry.
Your Insulin Price May Change Because:
Your plan updated its formulary.Your deductible restarted.Your insulin changed pricing tiers.Your PBM negotiated a new manufacturer agreement.A preferred insulin changed.Your pharmacy changed reimbursement.
What You Can Do If Your Insulin Suddenly Costs More
Don’t assume you have no options. Start by asking your pharmacist whether another therapeutically appropriate insulin is preferred under your plan’s current formulary, and contact your prescribing clinician before making any changes to your medication. Many manufacturers also offer copay cards, patient assistance programs, or cash-pay savings programs that may reduce your out-of-pocket costs if you qualify.
If you recently received notice of a formulary change, review the information carefully and contact your insurer’s customer service department to understand your alternatives before you run out of medication.
Before You Leave The Pharmacy
If your insulin price suddenly changes…
Ask whether your insulin is still on your plan’s preferred formulary.Ask whether a therapeutically appropriate preferred insulin is available.Check whether your deductible has reset.Ask about manufacturer savings programs or copay cards.Contact your insurer before skipping doses or switching medications.Speak with your prescribing clinician before making any insulin change.
Although another insulin may be covered at a lower cost, insulin products are not always interchangeable. Different formulations, delivery methods, and dosing schedules can require medical supervision. Never switch insulins without first speaking with the healthcare professional managing your diabetes.
Staying Ahead of Future Insulin Price Changes
Your insulin price isn’t determined solely by the insurance card in your wallet. Annual formulary updates, PBM negotiations, manufacturer rebates, deductible changes, and federal policy all influence what you ultimately pay at the pharmacy. Reviewing your prescription coverage each year, reading notices from your insurer, and asking questions before refilling your prescription can help you avoid unexpected costs and maintain uninterrupted access to the medication you need.
If your insulin price changes unexpectedly, remember that it doesn’t necessarily mean your insurance plan changed. Ask your pharmacist some of the questions above and contact your doctor right away. They may be able to provide you with some tools to help.
Have you ever been surprised by a change in your insulin price even though your insurance stayed the same? Share your experience and any tips you’ve found for lowering prescription costs in the comments.
What to Read Next
Medicare Drug Savings Surge: 1 in 3 Seniors Now Pays Less Than $35 a Month for Insulin—Here’s How
Colorado Just Capped Insulin at $35: The New Law Cutting Costs for Thousands
Scientists Develop a Pill That Can Deliver Insulin Without Needles
Drew Blankenship is a seasoned personal finance and lifestyle writer with more than a decade of professional writing experience crafting clear, actionable advice that helps savers and investors over 40 protect their wealth and make smarter everyday decisions. His bylines appear regularly on SavingAdvice.com, CleverDude.com, and other respected outlets, where he draws on deep industry knowledge to deliver practical insights on cost control, smart spending, and long-term financial security.
GIPHY App Key not set. Please check settings